| |
| |
|
| Insider
Information: |
Welch Daniel G |
| Relationship: |
|
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
681,552 |
|
|
Indirect Shares
|
123,508 |
|
|
| Direct
Value |
$7,743,872 |
|
|
|
Indirect Value
|
$4,223,974 |
|
|
| Total
Shares |
805,060 |
|
|
| Total
Value |
$11,967,846 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Chairman, CEO and Pres... |
2014-09-29 |
0 |
2004-08-12 |
0 |
Premium* |
|
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2023-12-14 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
Director |
2015-05-07 |
0 |
2014-05-27 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2023-06-07 |
21,605 |
2016-06-09 |
0 |
Premium* |
|
|
Avexis, Inc. |
AVXS |
Director |
2018-05-15 |
0 |
2018-03-13 |
0 |
Premium* |
|
|
Structure Therapeutics Inc. |
GPCR |
Director |
2023-02-07 |
0 |
2023-02-07 |
123,508 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
|
2024-05-24 |
659,947 |
2024-05-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
127 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
Director |
– • – |
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,402 |
41,931 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,145 |
14,445 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,503 |
9,649 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2022-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
17,745 |
0 |
- |
|
| GPCR |
Structure Therapeutics In... |
Director |
– • – |
2023-02-07 |
4 |
A |
$0.00 |
$0 |
I/I |
123,508 |
123,508 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,044 |
8,297 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,860 |
21,605 |
0 |
- |
|
| NUVB |
Nuvation Bio Ord Shs Clas... |
|
– • – |
2024-05-24 |
4 |
OE |
$1.64 |
$1,111,633 |
D/D |
659,947 |
659,947 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2012-12-03 |
4 |
OE |
$8.38 |
$26,137 |
D/D |
3,119 |
6,119 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2018-02-13 |
4 |
OE |
$8.38 |
$158,463 |
D/D |
16,881 |
66,100 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2013-10-01 |
4 |
OE |
$8.73 |
$436,500 |
D/D |
50,000 |
227,434 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-01-10 |
4/A |
OE |
$8.73 |
$436,500 |
D/D |
50,000 |
187,434 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-01-16 |
4/A |
OE |
$8.73 |
$436,500 |
D/D |
50,000 |
187,434 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-05-05 |
4 |
OE |
$8.73 |
$318,227 |
D/D |
28,913 |
127,019 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-05-06 |
4 |
OE |
$8.73 |
$318,251 |
D/D |
31,519 |
129,625 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-05-23 |
4 |
OE |
$8.73 |
$364,655 |
D/D |
34,544 |
128,475 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-08-05 |
4 |
OE |
$8.73 |
$1,304,476 |
D/D |
146,125 |
240,327 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2014-08-07 |
4 |
OE |
$8.73 |
$217,377 |
D/D |
24,900 |
119,102 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2012-06-08 |
4 |
D |
$9.27 |
$27,863 |
D/D |
(3,007) |
180,253 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2016-03-08 |
4 |
OE |
$9.82 |
$245,500 |
D/D |
25,000 |
41,819 |
0 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2013-06-04 |
4 |
D |
$9.89 |
$27,889 |
D/D |
(2,819) |
177,434 |
0 |
- |
|
| ITMN |
InterMune Inc |
President and CEO |
• • – |
2004-08-12 |
4 |
B |
$10.00 |
$250,000 |
D/D |
25,000 |
25,000 |
2.81 |
- |
|
| ITMN |
InterMune Inc |
President & CEO |
• • – |
2005-02-09 |
4 |
B |
$10.00 |
$100,000 |
D/D |
10,000 |
35,000 |
2.81 |
- |
|
| ITMN |
InterMune Inc |
Chairman, CEO and President |
• • – |
2012-06-04 |
4 |
A |
$10.10 |
$606,000 |
D/D |
60,000 |
206,601 |
0 |
- |
|
| ITMN |
InterMune Inc |
CEO and President |
• • – |
2010-03-22 |
4 |
OE |
$10.11 |
$199,994 |
D/D |
17,740 |
189,637 |
0 |
- |
|
127 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
